Robert Roscigno

Robert Roscigno has extensive experience in clinical development and scientific consulting within the pharmaceutical and biotechnology industries. Currently serving as Senior Vice President for Clinical Development in Pulmonary Vascular Disease at Gossamer Bio since July 2020, Robert previously held the position of Vice President in the same area. As the Principal of Robert F. Roscigno, PhD. Consulting, LLC since June 2007, Robert provides expert insights on therapeutic R&D for private equity funds and investors. Prior roles include Senior Vice President of Product Development at Liquidia Technologies and Executive Vice President at GeNO, LLC. Robert earned a PhD in Microbiology and Immunology from Duke University, following a BS in Biology from Trinity College-Hartford.